José M. Pinazo-Bandera, Miren García-Cortés, Antonio Segovia-Zafra, María Isabel Lucena & Raúl J. Andrade. (2022) Recreational Drugs and the Risk of Hepatocellular Carcinoma. Cancers 14:21, pages 5395.
Crossref
Rita B. Soares, Ricardo Jorge Dinis-Oliveira & Nuno G. Oliveira. (2022) An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava. Journal of Clinical Medicine 11:14, pages 4039.
Crossref
Vinícius Remus Ballotin, Lucas Goldmann Bigarella, Ajacio Bandeira de Mello Brandão, Raul Angelo Balbinot, Silvana Sartori Balbinot & Jonathan Soldera. (2021) Herb-induced liver injury: Systematic review and meta-analysis. World Journal of Clinical Cases 9:20, pages 5490-5513.
Crossref
Nan Mei, Tao Chen, Baitang Ning & Lei Guo. 2021. Nutraceuticals. Nutraceuticals
299
313
.
Ajay Srivastava & Prafulla Kumar. 2021. Nutraceuticals. Nutraceuticals
63
72
.
Palaniappan Saravanapriya & Kasi Pandima Devi. 2021. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases. Influence of Nutrients, Bioactive Compounds, and Plant Extracts in Liver Diseases
259
287
.
Amy Christine Brown. (2017) Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series. Food and Chemical Toxicology 107, pages 472-501.
Crossref
Christian Frenzel & Rolf Teschke. (2016) Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. International Journal of Molecular Sciences 17:5, pages 588.
Crossref
Flaminia Pantano, Roberta Tittarelli, Giulio Mannocchi, Simona Zaami, Serafino Ricci, Raffaele Giorgetti, Daniela Terranova, Francesco Busardò & Enrico Marinelli. (2016) Hepatotoxicity Induced by “the 3Ks”: Kava, Kratom and Khat. International Journal of Molecular Sciences 17:4, pages 580.
Crossref
Nan Mei, Jiekun Xuan, Tao Chen, Baitang Ning & Lei Guo. 2016. Nutraceuticals. Nutraceuticals
249
262
.
Dong Fu & Iqbal Ramzan. 2015. Phytotherapies. Phytotherapies
312
329
.
Xiaoyan Chen. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
64
.
Kenneth J. Sufka, Melissa J. Loria, Kevin Lewellyn, Jordan K. Zjawiony, Zulfiqar Ali, Naohito Abe & Ikhlas A. Khan. (2014) The effect of Salvia divinorum and Mitragyna speciosa extracts, fraction and major constituents on place aversion and place preference in rats. Journal of Ethnopharmacology 151:1, pages 361-364.
Crossref
Adejuwon Adewale Adeneye. 2014. Toxicological Survey of African Medicinal Plants. Toxicological Survey of African Medicinal Plants
99
133
.
Paula Gardiner, Denise Adams, Amanda C. Filippelli, Hafsa Nasser, Robert Saper, Laura White & Sunita Vohra. (2013) A Systematic Review of the Reporting of Adverse Events Associated with Medical Herb use among Children. Global Advances in Health and Medicine 2:2, pages 46-55.
Crossref
Anselm Wong, Zeff Koutsogiannis, Shaun Greene & Shona McIntyre. (2013) A case of hemolysis and methemoglobinemia following amyl nitrite use in?an individual with G6PD deficiency. Journal of Acute Medicine 3:1, pages 23-25.
Crossref
Dominique Larrey & Marie-Pierre Ripault. 2013. Drug-Induced Liver Disease. Drug-Induced Liver Disease
443
462
.
Rolf Teschke, Albrecht Wolff, Christian Frenzel, Johannes Schulze & Axel Eickhoff. (2012) Herbal hepatotoxicity: a tabular compilation of reported cases. Liver International 32:10, pages 1543-1556.
Crossref
V Garg. (2012) Facts about standardization of herbal medicine: a review. Journal of Chinese Integrative Medicine, pages 1077-1083.
Crossref
Amitava Dasgupta. 2012. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring
185
211
.
Ryan Bodkin, Sandra Schneider, Donna Rekkerth, Linda Spillane & Michael Kamali. (2012) Rhabdomyolysis associated with kava ingestion. The American Journal of Emergency Medicine 30:4, pages 635.e1-635.e3.
Crossref
Robert Clark Schutt, Claudio Ronco & Mitchell H. Rosner. (2012) The Role of Therapeutic Plasma Exchange in Poisonings and Intoxications. Seminars in Dialysis 25:2, pages 201-206.
Crossref
Rolf Teschke, Jerome Sarris & Isaac Schweitzer. (2012) Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited. British Journal of Clinical Pharmacology 73:2, pages 170-174.
Crossref
Karim Sedky, Racha Nazir, Aditya Joshi, Gagandeep Kaur & Steven Lippmann. (2012) Which psychotropic medications induce hepatotoxicity?. General Hospital Psychiatry 34:1, pages 53-61.
Crossref
Doris B. Strader, Victor J. Navarro & Leonard B. Seeff. 2012. Zakim and Boyer's Hepatology. Zakim and Boyer's Hepatology
462
475
.
James H. Lewis & David E. Kleiner. 2012. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
645
760
.
Chit Shing Jackson Woo, Jonathan See Han Lau & Hani El-Nezami. 2012. Recent Trends in Medicinal Plants Research. Recent Trends in Medicinal Plants Research
365
384
.
Sylvie Stacy. (2011) Relaxation Drinks and Their Use in Adolescents. Journal of Child and Adolescent Psychopharmacology 21:6, pages 605-610.
Crossref
Mamta Behl, Abraham Nyska, Rajendra S. Chhabra, Gregory S. Travlos, Laurene M. Fomby, Barney R. Sparrow, Milton R. Hejtmancik & Po C. Chan. (2011) Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava. Food and Chemical Toxicology 49:11, pages 2820-2829.
Crossref
Rolf Teschke & Vincent Lebot. (2011) Proposal for a Kava Quality Standardization Code. Food and Chemical Toxicology 49:10, pages 2503-2516.
Crossref
Ping Zhou, Shimon Gross, Ji-Hua Liu, Bo-Yang Yu, Ling-Ling Feng, Jan Nolta, Vijay Sharma, David Piwnica-Worms & Samuel X. Qiu. (2010) Flavokawain B, the hepatotoxic constituent from kava root, induces GSH‐sensitive oxidative stress through modulation of IKK/NF‐κB and MAPK signaling pathways. The FASEB Journal 24:12, pages 4722-4732.
Crossref
Rolf Teschke. (2010) Kava hepatotoxicity: pathogenetic aspects and prospective considerations. Liver International 30:9, pages 1270-1279.
Crossref
Jiwon W. Kim, Akiko Hattori & Paula V. Phongsamran. (2010) Drug-Induced Liver Disease. Critical Care Nursing Clinics of North America 22:3, pages 323-334.
Crossref
R. Teschke & A. Wolff. (2009) Kava hepatotoxicity: Regulatory data selection and causality assessment. Digestive and Liver Disease 41:12, pages 891-901.
Crossref
Valerie Robinson, Wilma F. Bergfeld, Donald V. Belsito, Curtis D. Klaassen, James G. Marks, Ronald C. Shank, Thomas J. Slaga, Paul W. Snyder & F. Alan Andersen. (2009) Final Report on the Safety Assessment of Piper Methysticum Leaf/Root/Stem Extract and Piper Methysticum Root Extract. International Journal of Toxicology 28:6_suppl, pages 175S-188S.
Crossref
Stacy S. ShordKanan Shah & Alvina Lukose. (2009) Drug—Botanical Interactions: A Review of the Laboratory, Animal, and Human Data for 8 Common Botanicals. Integrative Cancer Therapies 8:3, pages 208-227.
Crossref
Rolf Teschke, Alexander Genthner & Albrecht Wolff. (2009) Kava hepatotoxicity: Comparison of aqueous, ethanolic, acetonic kava extracts and kava–herbs mixtures. Journal of Ethnopharmacology 123:3, pages 378-384.
Crossref
Valerie Robinson, Wilma F. Bergfeld, Donald V. Belsito, Curtis D. Klaassen, James G. MarksJr.Jr., Ronald C. Shank, Thomas J. Slaga, Paul W. Snyder & F. Alan Andersen. (2019)
Final Report on the Safety Assessment of
Piper Methysticum
Leaf/Root/Stem Extract and
Piper Methysticum
Root Extract
. International Journal of Toxicology 28:2_suppl, pages 175S-188S.
Crossref
Lei Guo, Quanzhen Li, Qingsu Xia, Stacey Dial, Po-Chuen Chan & Peter Fu. (2009) Analysis of gene expression changes of drug metabolizing enzymes in the livers of F344 rats following oral treatment with kava extract. Food and Chemical Toxicology 47:2, pages 433-442.
Crossref
May Loo. 2009. Integrative Medicine for Children. Integrative Medicine for Children
106
130
.
Christine A. Haller. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics
1237
1245
.
Lingtak-Neander Chan. 2010. Handbook of Drug-Nutrient Interactions. Handbook of Drug-Nutrient Interactions
341
366
.
Donald G. Barceloux. 2008. Medical Toxicology of Natural Substances. Medical Toxicology of Natural Substances
525
531
.
D Jesse Wagstaff. 2008. International Poisonous Plants Checklist. International Poisonous Plants Checklist
287
326
.
S. Herrera & M. Bruguera. (2008) Hepatotoxicidad inducida por el uso de hierbas y medicamentos para perder peso. Gastroenterología y Hepatología 31:7, pages 447-453.
Crossref
Priyadarshini Raman, David L. DeWitt & Muraleedharan G. Nair. (2007) Lipid peroxidation and cyclooxygenase enzyme inhibitory activities of acidic aqueous extracts of some dietary supplements. Phytotherapy Research 22:2, pages 204-212.
Crossref
Saskia Lüde, Michael Török, Sandy Dieterle, René Jäggi, Karin Berger Büter & Stephan Krähenbühl. (2008) Hepatocellular toxicity of kava leaf and root extracts. Phytomedicine 15:1-2, pages 120-131.
Crossref
Amitava Dasgupta. 2008. Handbook of Drug Monitoring Methods. Handbook of Drug Monitoring Methods
235
261
.
Leonard B. Seeff. (2007) Herbal Hepatotoxicity. Clinics in Liver Disease 11:3, pages 577-596.
Crossref
Dominique Larrey. 2007. Drug-Induced Liver Disease, Second Edition. Drug-Induced Liver Disease, Second Edition
507
526
.
Natasha P. Clayton, Katsuhiko Yoshizawa, Grace E. Kissling, Leo T. Burka, Po-Chuen Chan & Abraham Nyska. (2007) Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract. Experimental and Toxicologic Pathology 58:4, pages 223-236.
Crossref
ADRIANE FUGH-BERMAN. 2007. Treatment of the Postmenopausal Woman. Treatment of the Postmenopausal Woman
683
690
.
L.A. Mitscher. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
405
430
.
Amitava DasguptaDavid W. Bernard. (2006) Herbal Remedies: Effects on Clinical Laboratory Tests. Archives of Pathology & Laboratory Medicine 130:4, pages 521-528.
Crossref
R. Brent Furbee, Kevin S. Barlotta, Melrose Kanku Allen & Christopher P. Holstege. (2006) Hepatotoxicity Associated with Herbal Products. Clinics in Laboratory Medicine 26:1, pages 227-241.
Crossref
Felix Stickel, Eleonora Patsenker & Detlef Schuppan. (2005) Herbal hepatotoxicity. Journal of Hepatology 43:5, pages 901-910.
Crossref
K N Woodward. (2016) The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products. Human & Experimental Toxicology 24:5, pages 219-233.
Crossref
Willis C Maddrey. (2005) Drug-Induced Hepatotoxicity. Journal of Clinical Gastroenterology 39:4, pages S83-S89.
Crossref
Ivonne M. C. M. Rietjens, Martijn J. Martena, Marelle G. Boersma, Wim Spiegelenberg & Gerrit M. Alink. (2005) Molecular mechanisms of toxicity of important food-borne phytotoxins. Molecular Nutrition & Food Research 49:2, pages 131-158.
Crossref
Yuzhong Ma, Karuna Sachdeva, Jirong Liu, Michael Ford, Dongfang Yang, Ikhlas A. Khan, Clinton O. Chichester & Bingfang Yan. (2004) DESMETHOXYYANGONIN AND DIHYDROMETHYSTICIN ARE TWO MAJOR PHARMACOLOGICAL KAVALACTONES WITH MARKED ACTIVITY ON THE INDUCTION OF CYP3A23. Drug Metabolism and Disposition 32:11, pages 1317-1324.
Crossref
Alex Sparreboom, Michael C. Cox, Milin R. Acharya & William D. Figg. (2004) Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents. Journal of Clinical Oncology 22:12, pages 2489-2503.
Crossref
Keith I. Block, Charlotte GyllenhaalMark N. Mead. (2016) Safety and Efficacy of Herbal Sedatives in Cancer Care. Integrative Cancer Therapies 3:2, pages 128-148.
Crossref
Eddy Pak, Karl T. Esrason & Victor H. Wu. (2016) Hepatotoxicity of Herbal Remedies: An Emerging Dilemma. Progress in Transplantation 14:2, pages 91-96.
Crossref
Laurent Peyrin-Biroulet, Hélène Barraud, Fabien Petit-Laurent, David Ancel, Jérôme Watelet, Laurence Chone, Hervé Hudziak, Marc-André Bigard & Jean-Pierre Bronowicki. (2004) Hépatotoxicité de la phytothérapie : données cliniques, biologiques, histologiques et mécanismes en cause pour quelques exemples caractéristiques. Gastroentérologie Clinique et Biologique 28:6-7, pages 540-550.
Crossref
Aline Charabaty Pishvaian, Bradley W. Trope & James H. Lewis. (2004) Drug-induced liver disease in 2003. Current Opinion in Gastroenterology 20:3, pages 208-219.
Crossref
U Werneke, J Earl, C Seydel, O Horn, P Crichton & D Fannon. (2004) Potential health risks of complementary alternative medicines in cancer patients. British Journal of Cancer 90:2, pages 408-413.
Crossref